Top Markets
#1 Akedo Akedo +57.11%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.98%
#4 Velvet Velvet +42.35%
#5 Black Phoenix Black Phoenix +34.56%
#6 τemplar τemplar +28.04%
#7 Ribbita by Virtuals Ribbita by Virtuals +19.92%
#8 Bitway Bitway +17.09%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +16.98%
#10 Cap Cap +16.13%
Coin of the day
Akedo Akedo
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Geffen Residence & Renewal Ltd Geffen Residence & Renewal Ltd

Geffen Residence & Renewal Ltd

GEFR
Rang in Aktien #38275
Geffen Residence & Renewal Ltd, previously known as Cannomed Medical Cannabis... Geffen Residence & Renewal Ltd, previously known as Cannomed Medical Cannabis Industries Ltd, is a company with a dual focus based in Tel Aviv-Yafo, Israel, established in 1999. It plays a significant role in the Israeli medical cannabis market, overseeing the growth, manufacturing, storage, distribution, and retail of these products. Additionally, the company operates a chain of pharmacies that offer a wide array of merchandise. These retail outlets provide personal care items, cosmetics, and various convenience goods. Their pharmaceutical offerings include prescription and over-the-counter medications, alongside natural health products, vitamins, and supplements. The pharmacies also stock first-aid supplies like plasters and bandages, as well as health monitoring devices such as thermometers and humidifiers.
Aktienkurs
$0.26456612
Marktkapitalisierung
$1.09M
Veränderung (1 Tag)
1.24%
Veränderung (1 Jahr)
13.83%
Land
IL
Handel Geffen Residence & Renewal Ltd (GEFR)

Kategorie

Healthcare
P/S-Verhältnis für Geffen Residence & Renewal Ltd (GEFR)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Geffen Residence & Renewal Ltd beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Geffen Residence & Renewal Ltd von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -
BE